| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.08 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.08 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.32 | 0.08 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.072 | 0.09 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.09 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.09 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.09 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 1.1 | 0.09 |